Serum Institute Gets Approval To Resume Indian Trial Of AstraZeneca COVID Vaccine - Source

Serum Institute of India has received Indian regulatory approval to resume local clinical trials of AstraZeneca's potential COVID19 vaccine, a source familiar with the matter said on Wednesday.
Market Update
SENSEX 31,622.48 -187.07(%)
NIFTY 9,898.00 -54.2(%)

Top News